Clinical Trial Update: The Comparison of the Efficacy of Once and Twice Daily Colchicine Dosage in Pediatric Patients With FMF [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial comparing once-daily versus twice-daily colchicine dosing in pediatric patients with Familial Mediterranean Fever has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Familial Mediterranean Fever

Drugs mentioned

• COLCHICINE (Colchicine)

Snippet

Sponsor: Saglik Bilimleri Universitesi Gulhane Tip Fakultesi | Conditions: Familial Mediterranean Fever | Phase 4 | Status: COMPLETED